This is a healthcare professional site
The information contained in the site is intended for US healthcare professionals only. By selecting “Okay” below, you verify that you are a licensed US healthcare professional.
No
CLDN18.2 Reporting Template
Download the guidance from our expert committee.
RING Trial Poster
Learn more about cross-platform and antibody comparison of CLDN18 expression.
IHC Assay Guide
Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.
ECP Testing Presentation
2023
Analytical and Clinical Performance of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples for Patient Identification in Two Phase 3 Trials of Zolbetuximab
Stay up to date on CLDN18.2
By signing up below, you will receive updates about testing for CLDN18.2 expression. You may also be contacted by an Astellas representative.
Thank you. Your submission was successful.
